Medico Intercontinental Faces Flat Sales Amid Weak Long-Term Fundamentals and Bearish Market Indicators
Medico Intercontinental, a microcap in the finance/NBFC sector, has experienced a recent evaluation adjustment amid flat financial performance for the quarter ending December 2024. Despite a decline in net sales, the company shows a 25.5% profit increase over the past year, indicating some resilience in a challenging market.
Medico Intercontinental, a microcap player in the finance/NBFC sector, has recently undergone an adjustment in evaluation, reflecting the company's current market dynamics. The latest assessment highlights a flat financial performance for the quarter ending December 2024, with net sales reported at Rs 19.15 crore, indicating a decline compared to the previous four-quarter average. The company's long-term fundamental strength appears to be weak, with a compound annual growth rate (CAGR) of 4.70% in net sales. Additionally, the stock is technically positioned within a bearish range, with various indicators such as MACD and Bollinger Bands suggesting a challenging market environment.
Despite these challenges, Medico Intercontinental maintains a relatively attractive valuation, evidenced by a return on equity (ROE) of 10 and a price-to-book ratio of 0.8. Over the past year, while the stock has faced significant declines, its profits have shown an increase of 25.5%, contributing to a PEG ratio of 0.3.
For those interested in further insights, Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
